Interleukin (IL)-6, a potent proinflammatory
cytokine, is suggested to be a risk factor for
choroidal neovascularization (CNV) because of its increased levels in the serum of patients with
age-related macular degeneration; however, the role of
IL-6 in CNV has not been defined. The present study reveals the critical contribution of
IL-6 signaling and its downstream STAT3 pathway to the murine model of
laser-induced CNV. CNV induction by
laser treatment stimulated
IL-6 expression in the retinal pigment epithelium-choroid complex, and antibody-based blockade of
IL-6 receptor or genetic ablation of
IL-6 led to significant suppression of CNV. CNV generation was accompanied by STAT3 activation in choroidal endothelial cells and macrophages, and
IL-6 receptor blockade resulted in selectively inhibited phosphorylation of STAT3 but not
extracellular signal-regulated kinase 1/2. Consistently, pharmacological blockade of STAT3 pathway also suppressed CNV. In addition,
IL-6 receptor neutralization led to significant inhibition of the in vivo and in vitro expression of
inflammation-related molecules including
monocyte chemotactic protein,
intercellular adhesion molecule-1, and
vascular endothelial growth factor, and of macrophage infiltration into CNV. These results indicate the significant involvement of
IL-6 receptor-mediated activation of STAT3 inflammatory pathway in CNV generation, suggesting the possibility of
IL-6 receptor blockade as a therapeutic strategy to suppress CNV associated with
age-related macular degeneration.